Cancer Predisposition in Neonates and Infants: Recognition, Tumor Types, and Surveillance

Clin Perinatol. 2021 Mar;48(1):1-14. doi: 10.1016/j.clp.2020.11.001. Epub 2021 Jan 12.

Abstract

Pediatric cancer is rare, and malignancy during the neonatal period even rarer. However, several malignancies can present in infancy, most commonly in the form of solid tumors. Specific cancer types, bilateral or multifocal disease, associated congenital malformations, and/or cancers in close relatives may herald a diagnosis of an underlying cancer predisposition syndrome. For many patients, surveillance protocols are recommended beginning at birth or during the course of maternal prenatal care. Advantages and disadvantages of genetic testing and surveillance should be discussed with families using a multidisciplinary approach, with input from a genetic counselor with expertise in pediatric cancer predisposition.

Keywords: Cancer predisposition; Cancer surveillance; Infant malignancy; Neonatal malignancy.

Publication types

  • Review

MeSH terms

  • Child
  • Family
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Genotype
  • Humans
  • Infant
  • Infant, Newborn
  • Neoplasms* / epidemiology
  • Neoplasms* / genetics
  • Pregnancy
  • Syndrome